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Abstract
O-antigen, the most surface exposed moiety of bacterial lipopolysaccharide (LPS), plays
several roles in pathogenicity. The biosynthesis of O-antigen starts by the formation of a
phosphoanhydride bond linking a sugar phosphate with a membrane isoprenoid lipid
phosphate. Two distinct families of integral membrane proteins catalyze this reaction.
The protein WecA is the prototypic member of one of these families, termed the
polyisoprenyl-phosphate N-acetylaminosugar-1-phosphate transferase (PNPT) family.
Because the donor nucleotide sugar is only available in the cytosol, cytosolic exposed
regions of WecA are expected to be critical for the catalytic activity of the enzyme.
Therefore, elucidating an accurate topological map of WecA is essential to understand its
function. While a topological model has been determined with some level of accuracy in
certain regions of WecA, various protein-protein, protein-lipid, and protein-aqueous
interfaces are not precisely mapped and we have also found inconsistencies between in
silico prediction models and experimental data. We hypothesize that the borders between
the transmembrane domains (TMs) and the cytosolic loops of WecA are critical for its
function. In particular, this thesis focuses on cytoloops 1 and 4 (including the universally
conserved VFMGD motif), and TMs IV and V (a putative interaction site for the lipid
substrate). The locations of these border residues were identified by the topological
accessibility of specific amino acids using the substituted cysteine accessibility method
(SCAM) combined with PEGylation. This approach offers several advantages over other
classical SCAM methods, especially by avoiding the need to purify the labeled protein
after sulfhydryl chemistry. PEGylation involves the covalent mass labeling of accessible
sulfhydryl groups with the large thiol reagent methoxy-polyethylene glycol-maleimide
(PEG-Mal, 5 kDa), and detection using a gel shift assay. Orientation is differentiated by
treatment of EDTA-permeablized cells compared to treatment in membrane preparations.
This thesis describes the adaptation and use of PEGylation for the topological analysis of
WecA. The results provide further refinement of the WecA topological map, and the
method can be extended to other integral membrane proteins involved in O-antigen
assembly.
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Chapter 1

Introduction

2
Introduction
1.1 The bacterial cell envelope
The cell envelope of Gram-negative bacteria prevents harmful compounds from entering
the bacterial cell, maintains the cell’s rigidity and shape, and allows entry of nutrients [1,
2]. The cell envelope consists of an inner membrane, a peptidoglycan layer, and an outer
membrane (Figure 1). The inner membrane is a phospholipid bilayer composed primarily
of phospholipids and integral membrane proteins. Phosphatidylethanolamine and
diphosphatidylethanolamine are the most abundant lipids in the inner membrane. The
enzymes responsible for the synthesis of peptidoglycan and select outer membrane
components are major proteins located in the inner membrane, in addition to secretion
systems, efflux pumps, membrane sensor kinases, and components of the respiratory
chain [3].
Glycan chains of N-acetylglucosamine and N-acetylmuramic acid cross-linked by a
short polypeptide form a net-like polymeric structure known as cell wall peptidoglycan or
murein. The chemistry of cross-links and the peptide composition vary between bacterial
species (reviewed in [4]). Essential for cell survival, the peptidoglycan cell wall
maintains cell integrity by withstanding internal turgor (osmotic) pressure. Also, the
peptidoglycan layer acts as a scaffold for other cell envelope components, such as the
peptidoglycan-associated lipoprotein that anchors the outer membrane to the
peptidoglycan [2].
The outer membrane is an asymmetric bilayer composed of phospholipids,
lipoproteins, polysaccharides such as capsular polysaccharides (CPS or capsule),
enterobacterial common antigen (ECA), lipopolysaccharide (LPS), and proteins, and is
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Figure 1. Schematic representation of the Gram-negative bacterial cell envelope (Modified from [5]).
The cell envelope consists of 3 layers: the inner membrane (IM), the periplasmic space, including the
peptidoglycan, and the outer membrane (OM). Proteins are found in all 3 layers and surface
polysaccharides like LPS protrude out of the outer membrane into the extracellular space.
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selectively permeable by preventing the diffusion of macromolecules, neutral and anionic
substances and hydrophobic molecules [6-8]. The outer membrane confers Gramnegative bacteria resistance to various bactericidal compounds such as bile salts,
hydrophobic antibiotics, and detergents [2, 9, 10]. These properties of the outer
membrane also help the bacteria to evade host defenses such as phagocytosis and
complement killing [11, 12]. A defining feature of the outer membrane bilayer is its
asymmetry; the inner leaflet has a similar lipid composition as the inner membrane while
the outer leaflet has a low concentration of phospholipids with LPS being the dominant
structural component [2, 9, 10].

1.2 Lipopolysaccharides
1.2.1 Structure of LPS
LPS is a heat-stable and negatively charged surface glycolipid that has 3 structural
components: lipid A, core oligosaccharide (OS), and O-antigen (OAg). LPS is anchored
to the outer leaflet of the outer membrane by the hydrophobic lipid A portion, which is
also the most conserved LPS moiety (reviewed in [13]; Figure 2).
The next most conserved structural component of LPS is the core OS,
consisting of 8 to 12 sugar residues in total, which can be further subdivided into an inner
core and outer core. Rare sugars like Kdo and L- or D-glycero-D-manno-heptose are
characteristic of the inner core OS (reviewed in [14]), and modifications, like
phosphorylation, are common to the inner core heptoses. D-glucose (Glc), D-galactose
(Gal), D-glucosamine (GlcN), N-acetylglucosamine (GlcNAc), and Nacetylgalactosamine (GalNAc) are common hexoses found in the outer core OS.
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Figure 2. General structure of lipopolysaccharide (Modified from [5]). The three main structural
components of LPS are: the lipid A, the core oligosaccharide, including the inner and outer core, and the Oantigen. Kdo = α-3-deoxy-D-manno-oct-2-ulosonic acid; n= number of O units.
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The outer core OS is the site of attachment for the OAg, which is the most surface
exposed LPS structural component.
The OAg is also the most heterogeneous structural component of LPS. In E. coli
alone, 170 serologically different OAg molecules have been identified [15]. OAg is a
polymer of polysaccharide subunits or O units, which are composed of unique
monosaccharides (reviewed in [16]) and can be linear or branched. Due to the variation in
types of sugars, their sequence in the subunit, and the type of linkages between sugars,
there are numerous possible O unit structures. Therefore, OAgs are highly variable across
species and even strains. Additional variability exists through modifications such as
acetylation or glycosylation. The variation in the OAg structure accounts for a wide range
of serotypes in Gram-negative bacterial species.

1.2.2 LPS biosynthesis
The lipid A-core and OAg are synthesized in separate biosynthetic pathways. The
core OS is assembled onto preformed lipid A by sequential glycosyltransfer reactions
while OAg is assembled onto undecaprenyl-phosphate (Und-P) forming an Und-PPlinked saccharide. Both synthesis pathways are initiated at the cytoplasmic face of the
inner membrane and require a translocation step to the periplasmic face of the inner
membrane. MsbA, an inner membrane ATP Binding Cassette (ABC)-transporter, is
responsible for the transport of the lipid A-core across the inner membrane (reviewed in
[13]) while the OAg biosynthesis, initiated by WecA, will be discussed in section 1.3.
Once both molecules are translocated across the inner membrane to the periplasmic face,
they become ligated together with the release of Und-PP. Und-PP is then
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dephosphorylated into Und-P by a poorly characterized but conserved pathway. Finally,
the complete LPS molecule is transported through the periplasmic space and then onto
the outer leaflet of the outer membrane by the Lpt pathway [17].

1.3 Biosynthesis and assembly of O-antigen
OAg biosynthesis starts at the cytosolic face of the inner membrane with the
formation of an Und-PP-linked intermediate. All cells produce polyisoprenoids, which
are lipid carrier intermediates for the biosynthesis of complex carbohydrate structures.
Polyisoprenol-phosphate-linked saccharides are needed in the early stages of protein
glycosylation in eukaryotes and prokaryotes, as well as for bacterial cell wall
peptidogylcan and surface polysaccharide synthesis. Nucleotide sugars, available as
soluble molecules in the cytosol, donate carbohydrates for the synthesis of the saccharide
moiety. In contrast, the phosphoisoprenol acceptor is embedded within the lipid
membrane bilayer. After assembly, the phosphoisoprenol-linked saccharide molecules
must cross the lipid bilayer for further processing. Therefore, the transmembrane
movement of phosphoisoprenol-linked saccharides represents a conserved, obligatory
step of significant biological importance in all types of cells [17-21].
Depending on the specific type of assembly system, the Und-PP-OAg is
subsequently elongated, translocated across the membrane, and polymerized, ultimately
resulting in an Und-PP-linked polymeric OAg localized to the periplasmic side of the
inner membrane. Finally, the OAg glycan moiety becomes ligated onto the lipid A-core
OS resulting in the formation of a complete LPS molecule while the Und-PP
polyisoprenoid carrier is dephosphorylated into Und-P by several membrane-associated
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phosphatases and recycled to reinitiate OAg biosynthesis [17-20, 22, 23]. Two main
pathways are responsible for the assembly of OAg: the Wzy/Wzx-dependent pathway
and various types of ABC-transporter-dependent pathways.

1.3.1 Wzy/Wzx-dependent O-antigen biosynthesis
The Wzy/Wzx pathway involves the synthesis of O-units by the successive
addition of monosaccharides at the non-reducing end of the molecule. This pathway is
responsible for the synthesis of the majority of OAgs, and especially heteropolymeric
OAgs. Wzx is an inner membrane protein with 12 predicted TMs that translocates the Ounits across the inner membrane. Wzx proteins share little primary sequence similarity
such that they can be used as genetic markers for distinguishing among specific OAgs.
Wzy polymerizes the translocated O-units. Polymerization proceeds sequentially from the
reducing end of the growing polymer to the non-reducing end of Und-PP-linked units.
Wzy proteins are also inner membrane proteins with 11-13 predicted TMs and also share
little sequence similarity. Unlike Wzx, Wzy proteins from different O-types are not
interchangeable and display specificity for the O-unit. Several Wzy proteins were
examined with topology prediction programs and it appears that Wzy proteins possess a
large periplasmic loop that may be important in the recognition of the OAg subunit.
The third component to the Wzy/Wzx-dependent pathway is the chain-length
regulating protein Wzz. These proteins are in the inner membrane, and all have a
periplasmic loop with a predicted coiled-coil structure flanked by two TMs. Wzz controls
the degree of polymerization by Wzy and appears not to be specific for a given O-repeat
subunit structure. It is thought these three proteins work together as a functional complex
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(Figure 3). Once the OAg molecule is complete, the integral membrane ligase WaaL
transfers the complete OAg from Und-P ‘en bloc’ onto the pre-formed lipid A-core to
form a covalent, glycosyl linkage between the two molecules, resulting in a complete
LPS molecule which is exported to the outer surface of the outer membrane [24-35].
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Figure 3. Wzy/Wzx-dependent O-antigen biosynthesis pathway in E. coli (Modified from [5]).
Initiation of OAg biosynthesis occurs at the cytosolic face of the inner membrane. WecA catalyzes the
phosphoanhydride bond formation between GlcNAc-1P and Und-P to yield Und-PP-GlcNAc. Membrane
associated glycosyltransferases add additional sugars onto the Und-PP-GlcNAc intermediate forming O
units. Wzx translocates the O unit across the inner membrane to the periplasmic face where Wzy
polymerizes the O units together. Wzz regulates the degree of polymerization. Upon completion of
polymerization, WaaL transfers the OAg from Und-PP to the preformed lipid A-core, and covalently
ligates the LPS molecule together.
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1.3.2 ABC transporter-dependent O-antigen biosynthesis
The ATP-binding cassette (ABC) transporter pathway translocates the complete
OAg across the inner membrane in a process that requires ATP hydrolysis. This pathway
operates primarily in the synthesis of linear, homopolymeric OAg molecules. ABC
transporters are also involved in the export of lipid-linked glycans for the assembly of
glycoproteins, teichoic acids, and CPSs. Seven different classes can be identified that
represent ABC transporter-dependent pathways. Six of these classes consist of
independent pairs of TM polypeptides and polypeptides containing the nucleotidebinding domains (NBDs) [17, 36].
Elongation of the entire OAg occurs at the cytoplasmic face of the inner
membrane by glycosyltransferases that add sugars to the Und-PP-sugar (Figure 4). Unlike
Wzy-dependent synthesis, the GlcNAc residue is transferred to lipid A-core OS during
ligation only once per chain, therefore it is not found within the O-repeat unit structure
itself. The O-specific polysaccharides formed by this pathway display strain-specific
chain length (modal) distributions despite that the ABC-transporter dependent pathway
does not involve a Wzz protein. The chain-terminating WbdD protein modifies the
nonreducing end of these polymers, causing termination of polymerization, therefore
controlling the length of these polymers [13, 17, 36].
ABC-2 transporters contain a TMD component, Wzm, an inner membrane protein
with an average of six TMs, and a hydrophilic NBD protein, designated as Wzt. Wzm
homologues display little primary sequence similarity, while Wzt homologues are much
more highly conserved, especially in the NBD domain. Contrarily, Wzm proteins are
interchangeable between different OAgs, while Wzt proteins are not. Again, once
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translocated, WaaL mediates ligation of the OAg onto lipid A-core at the periplasmic
face of the inner membrane [13, 37].
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Figure 4. ABC transporter-dependent O-antigen biosynthesis pathway in E. coli (Modified from [5]).
Initiation of OAg biosynthesis occurs at the cytosolic face of the inner membrane to form the isoprenoid
linked OAg intermediate. Soluble glycosyltransferases add additional sugars onto the intermediate to
complete OAg. The ABC transporter, composed of Wzt and Wzm, translocates the complete OAg across in
the inner membrane to the periplasmic face. WaaL covalently ligates the OAg from Und-P to the preformed
lipid A-core.
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1.3.3 Synthase-dependent OAg biosynthesis
The O:54 antigen of S. enterica serovar Borreze is the only known example of the
synthase-dependent O-polysaccharide. The O:54-specific polysaccharide is a linear
homopolymer of N-acetylmannosamine (ManNAc). Synthases are inner membrane
proteins that catalyze a vectorial polymerization reaction by a processive mechanism
resulting in the extension of the polysaccharide chain with the simultaneous extrusion of
the nascent polymer across the inner membrane. The exact mechanism of elongation,
translocation, and chain termination are still unknown [17, 36].

1.4 Initiating enzymes
Two major families of enzymes catalyze the initiation reaction of OAg biosynthesis:
Polyisoprenyl-phosphate N-acetylaminosugar-1-phosphate transferases (PNPTs) and
Polyisoprenyl-phosphate hexose-1-phosphate transferases (PHPTs) [36]. See figure 5 for
a schematic topological comparison of the two major families.

1.4.1 PHPT family
All PHPT transferases are inner membrane proteins found only in prokaryotes,
and share a high level of primary sequence similarity. The prototypic enzyme of this
family is WbaP, which initiates OAg biosynthesis in S. enterica by transferring galactose1-phosphate from UDP-galactose (UDP-Gal) to Und-P, yielding Und-P-P-Gal [38-41].
WbaP has three domains with five predicted TM helices. The hydrophobic N-terminal
domain spanning four TMs has no known function but contributes to the overall stability
of the protein in the membrane [40]. The large, central periplasmic loop between TM 4
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Figure 5. Schematic representation of the topologies of the PHPT and the PNPT prototypic enzymes.
Roman numerals indicate the TM helices. Numbers indicate the cytosolic loops. A) Topological
representation of WbaP from S. enterica serovar Typhi. The topology was predicted using the TMHMM,
MEMSAT, TOPPRED, and PHD programs. B) Topological representation of WecA from E. coli. The
model was originally derived using the TMHMM program and the TM boundaries were experimentally
refined by SCAM [20].
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and TM 5 is implicated in modulating chain length distribution of OAg [39, 42]. Most
importantly, the C-terminal domain, including TM5 and the tail, is sufficient for in vitro
and in vivo enzymatic activity, and its localization was confirmed by trypsin cleavage and
GFP reporter experiments [39, 42]. Other members of the PHPT family initiate the
synthesis of various types of glycans such as: colonic acid in E. coli K-12 [39, 42, 43],
K30 capsule in E. coli 09:K30 [42, 44, 45], type 2 capsule in Streptococcus pneumoniae
[39, 46, 47], and glycans for S-layer protein glycosylation in Geobacillus
stearothermophilus [39, 48] and general protein glycosylation [36].

1.4.2 PNPT family
The PNPT family of proteins has prokaryote and eukaryote members. PNPT
enzymes catalyze the transfer of N-acetylaminosugar-1-phosphate from the donor, UDPN-acetyl-aminosugar to the lipid acceptor. Und-P is the only lipid acceptor found in
bacteria, whereas the lipid acceptor in eukaryotes and Archaea is dolichylphosphate (DolP) [49]. Dol-P and Und-P both contain an α-isoprene unit. This is the phosphorylated end
of the molecule that participates in the phosphoanhydride bond formation with the Nacetylaminosugar-1-P. Und-P contains 11 isoprene units, all of which are fully
unsaturated, while Dol-P can be made of 15-19 isoprene units that have a saturated αisoprene [50]. Eukaryotic and bacterial evolutionary divergence may be reflected by their
ability to discriminate their lipid substrate (Figure 6).
Eukaryotic PNPTs are involved in asparagine N-linked protein glycosylation,
transferring GlcNAc-1-phosphate from UDP-GlcNAc to Dol-P forming the product
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Figure 6. Lipid carriers utilized by the PNPT family of enzymes (Modified from [17]). Structure of
isoprenoid lipids. A) Und-P. B) Dol-P. Und-P has 11 isoprene units and Dol-P has 15-19 isoprene units.
The α isoprene unit is the one linked to the phosphate mocule. n = number of total isoprene units.
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Dol-PP-GlcNAc [51-53]. The bacterial PNPT WecA, the prototype for the PNPT family,
is a UDP-GlcNAc:UndP GlcNAc-1-phosphate transferase. This reaction is involved in
initiation of OAg and ECA synthesis in enteric bacteria [26, 27, 54-58]. Contrary to other
PNPT enzymes, WecA has relaxed specificity and can also use UDP-GalNAc [54, 59].
Other bacterial PNPTs include WbpL, WbcO, and MraY [59-62]. WbpL and WbcO are
thought to be specific for UDP-N-acetyl-D-fucosamine (UDP-FucNAc) and/or UDP-Nacetyl-D-quinovosamine (UDP-N-QuiNAc). MraY proteins initiate peptidoglycan
synthesis by catalyzing the transfer of N-acetylmuramoyl-pentapeptide 1-phosphate
(MurNAc-pentapeptide-1P) from UDP-MurNAc-pentapeptide to Und-P forming UndPP-MurNAc-pentapeptide.
Prokaryotic and eukaryotic PNPTs are polytopic inner membrane proteins sharing
six discrete, conserved domains found in bacterial and eukaryotic homologues [22, 23,
53, 63-66]. Due to sequence similarity and location at the transmembrane:cytosol
interface, these domains were proposed to be involved in catalysis or substrate binding
[53]. The PNPT family members have five cytosolic loops (cytoloops). Conserved
regions in cytoloops 2, 3, and 4 (including the highly conserved VFMGD motif) are
found in all bacterial PNPT members and likely contribute to form the catalytic site of
these enzymes [51, 53, 65, 67]. A high degree of variability was noted in the large
cytoloop 5, which is proposed to be involved in nucleotide sugar specificity (Figure 7)
[51, 65].
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1.5 Structure-function of WecA
1.5.1 Topology of WecA
WecA is a 367 amino-acid bacterial sugar-phosphate transferase with a molecular
mass of 40.9 kDa. The WecA topology was initially predicted in silico using the
transmembrane hidden Markov model (TMHMM) and compared to known topologies of
MraY and other PNPT family proteins [20, 22, 51, 67, 68]. Reporter fusions and the
substituted cysteine accessibility method (SCAM) were utilized to refine the predicted
model and confirm that WecA has 11 transmembrane helices (TMs), 5 cytoplasmic loops,
5 periplasmic loops, and a cytosolic C-terminus (Figure 7) [20, 51].
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Figure 7. Predicted topology of E. coli MV501 WecA (Modified from [51]). The N-terminus is in the
periplasm, the 5 cytoloops are indicated by numbers 1-5, and the C-terminus is in the cytoplasm. The
dotted-line circle indicates the updated location of the highly conserved VFMGD motif (based on
biotinylation of aspartic acid 217). The asterisks indicate the controversial residues D35 and R209.Other
critical residues are indicated by circles with white backgrounds while the squares indicate the periplasmic
and cytoplasmic controls.
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1.5.2 Regions of WecA essential for catalysis
Numerous attempts have been made to define regions and individual amino acids
in WecA that are functionally significant. TMs I through III are essential for function but
not for membrane insertion [69]. TM XI is essential for stability of the protein in the
membrane while the C-terminal tail of WecA is dispensable for function [22]. The highly
conserved arginine (R) at position 265, and the histidine-isoleucine-histidine-histidine
(HIHH) motif at positions 279-282 within cytoloop 5 are thought to play a role in UDPGlcNAc recognition [22, 65]. The HIHH sequence is reminiscent of the histidineisoleucine-glycine-histidine (HIGH) motif conserved in the active site of nucleotide
phosphate binding proteins, such that amino acid replacements of R265 and the HIHH279282

motif resulted in loss of OAg production and binding of the transition state analogue,

tunicamycin [22, 70, 71]. Replacement of H279 with glycine (G) demonstrated that this
residue is critical for enzyme function [71].
Aspartic acid (D) residues at positions 90 and 91 in cytoloop 2, and 156 and 159
in cytoloop 3 are also conserved in the PNPT family but are functionally distinct [22, 23].
The conserved aspartic acids in cytoloop 2 of WecA were proposed to bind the cofactor
Mg2+, while D156 and D159 were proposed to be involved in UDP-GlcNAc binding or
modification. Only D156 is essential for catalysis. Amino acid substitutions in all of the
conserved aspartic acids cause defects in OAg initiation, supporting these hypotheses [20,
23].
Eukaryotic and prokaryotic PNPT family members share another highly
conserved region, the VFMGD motif (Figure 8). This motif in MraY was proposed to
contain a catalytic nucleophile, D267 [72], while experiments in our laboratory suggest
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Figure 8 (Modified from [51]). ClustalW alignment of the highly conserved VFMGD motif among PNPT
family members. Alignment shows protein sequences from E. coli MraY, B. subtilis MraY, H. sapiens
GPT, Fission Yeast GPT, and E. coliI WecA. An asterisk (*) indicates completely conserved amino acids,
and a colon (:) indicates partially conserved amino acids.
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the comparable motif and D217 in WecA does not [51]. The size of the amino acid side
chains and the polarity at the D217 position are important for enzymatic activity, as were
the replacements of the surrounding residues with alanine. Therefore this highly
conserved motif is proposed to define a region in PNPT proteins that contributes to the
active site [51].

1.6 Methods for predicting and determining inner membrane protein topologies
Topological methods provide insight into essential amino acids, organization, and
structure of inner membrane proteins. There are several methods to predict and
experimentally probe the topology of membrane proteins.

1.6.1 In silico analysis
The precise identification of TMs is important for the functional annotation and
the functional analysis when studying any membrane protein. A major obstacle when
studying membrane proteins is the difficulty in experimental determination of their threedimensional structures, especially if no prior topology prediction studies have been
performed. Experimental studies are therefore complemented, and generally initiated, by
computational studies using neural networks, Hidden Markov models, and support vector
machines [73]. Most topology predictions methods, such as the Transmembrane Hidden
Markov Model (TMHMM), are based on processing multiple-sequence alignment data,
and several assumptions such that hydrophobic regions are potential TMs, coiled-coil
regions are potential protein-interaction domains, and hydrophilic stretches are potential
loops [73, 74]. TM predictions are possible since most TM α-helices contain long
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stretches of 17-25 non-polar hydrophobic residues. These hydrophobic regions cross the
lipid membrane many times, and contain connecting loops with more polar residues. The
orientation of the helices, whether inward or outward, is also important to the overall
topology of the protein. This is highlighted by the well-established “positive-inside” rule
that predicts that a hydrophobic region followed by positively charged residues, such as
arginine and lysine, may indicate an inward orientation of the helix [73-76]. The
TMHMM program takes advantage of these postulates and is therefore reasonably
accurate, providing near 80% confidence based on analyses of model membrane proteins
[73, 75]. In silico methods for predicting membrane protein topology provide a general
topological model of the protein of interest, especially when different computer programs
afford similar predictions [68, 73, 76]. However, non-canonical residues in TMs, like
positively or negatively charged amino acids can lead to wrong predictions.

1.6.2 Reporter fusions
Topological arrangement of proteins within the bacterial cytoplasmic membrane
has been successfully studied using gene fusions techniques. The most widely used
reporters are β-galactosidase (LacZ), and alkaline phosphatase (PhoA).
The periplasmic alkaline phosphatase PhoA and the cytoplasmic β-galactosidase
LacZ are reporter proteins that have reciprocal activity in different cellular
compartments; therefore, these enzymes are used as sensors for the subcellular locations
of segments of integral membrane proteins (Figure 9). PhoA is only enzymatically active
when it is translocated across the inner membrane into the periplasmic space. This is
visualized when the bacteria expressing enzymatically active PhoA appear blue when
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Figure 9. Schematic representation of the enzymatic activity of reporter fusions. Blue indicates when
the fusion protein is enzymatically active as the attached hybrid moiety is localized to the correct cellular
compartment. Bacteria appear blue when grown on medium containing the appropriate substrate. White
indicates an enzymatically inactive fusions and bacteria will appear colourless.
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grown on medium containing the substrate analogue X-P. If the PhoA moiety remains in
the cytosol then the bacteria appear colourless as PhoA is not enzymatically active.
Contrarily, LacZ is only enzymatically active when this moiety of the hybrid protein
remains in the cytoplasm. This is visualized when bacteria are grown on medium
containing the substrate analog X-Gal and appear blue. Again, if LacZ is translocated to
the periplasm (opposite to PhoA) the bacteria will appear colourless, indicating an
enzymatically inactive fusion.
The method of reporter fusions can give inconclusive results. This is most likely
due to disruption of the tertiary structure of the protein of interest because of truncation
or alternate conformations, depending on which reporter protein is present. Correct
topological information is only provided if topogenic signals from the target protein are
present before the fusion junction to the reporter enzyme [77-80]. Junctions closer to the
TM borders and even within TMs can lead to false positive and negative results, making
the accurate topological assignment very difficult.

1.6.3 Substituted cysteine accessibility method (SCAM)
The analysis of protein structure has been greatly advanced by a technique which
involves the modification of thiol groups in proteins and is designated SCAM. It is a
biochemical approach to experimentally determine the topology of inner membrane
proteins. SCAM allows the residues on the water-accessible surface of membrane
proteins to be systematically mapped. It takes advantage of thiol-reacting molecules,
such as maleimides, combined with membrane-permeable and -impermeable reagents
that help define the orientation of cytoplasmic residues versus periplasmic residues, in
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addition to the length and orientation of TM segments. TM residues are prevented from
reacting with maleimides because of their presence in the hydrophobic space so mutating
residues around the border of the predicted TM regions can help refine their predicted
length [81-87]. In the presence of water, the double bond of the maleimide ring breaks to
form an irreversible thiolate (Figure 10). Maleimide reacts 1,000 times more efficiently in
a slightly acidic pH range of 6.5-7.5, whereas an increase to above a pH 8 leads to
reactivity with primary amines, and hydrolysis of the maleimide ring. Thus, maleimides
are particularly suited for this chemistry as they are virtually unreactive until they
encounter an available sulfhydryl group [82, 88, 89]. Further, SCAM allows topological
assessment under conditions in which inner membrane proteins remain properly folded.
A key point of this methodology is the reliance on a cysteineless protein that remains
functional, and allows the introduction of single cysteines at specific sites. Single amino
acid changes are less likely to disrupt tertiary structure of the protein and alter its native
topology, a problem commonly found with reporter fusions. Therefore, SCAM provides
the basis for better refinement of the topology of the protein of interest [82, 85, 90, 91].
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Figure 10. Schematic representation of the sulfhydryl reaction. Maleimide molecules become reactive
when they encounter available sulfhydryl groups, such as single cysteines exposed on the protein surface in
extra membrane loops. In the presence of water, the double bond of the maleimide ring breaks to form an
irreversible thiolate, while the terminal monomethoxy group prevents cross-linking to other available
thiols. P = protein of interest; SH = sulfhydryl group (substituted cysteine).
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The classical SCAM method employs biotin maleimide and a blocker reagent
such as MTSET. Biotin maleimide is internalized by bacteria and labels available
cysteines in extramembrane loops, whether in the cytosol or the periplasmic space.
MTSET is a positively charged, thiol-reactive reagent that because it cannot cross the
inner membrane blocks periplasmic cysteine residues from biotinylation (Figure 11).
Cysteine residues in TMs are not labeled due to their hydrophobic environment that
prevents access of water molecules that are critical for biotinylation. The difficulty with
this strategy is that the biotinylated protein must be purified prior to detection with
streptavidin. Purification is critical to separate the modified protein from the background
of other native proteins in the membrane that became biotinylated in their native
cysteines. Therefore, this classical biotinylation method for SCAM can give considerable
background, and is highly labour-intensive and time consuming [20, 51, 92]. An
alternative strategy based on PEGylation overcomes this shortcoming and will be
discussed in the next section.
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Figure 11. Schematic representation of SCAM (Modified from [82]). A protein of interest containing a
single substituted cysteine either to the periplasmic (left half of the circle) or cytoplasmic (right half of the
circle) side of the membrane is expressed in cells. Membrane preparations result in inside-out orientated
vesicles (ISOV), which are opposite orientations for the same cysteines. Half of the cells or ISOV is reacted
with a detectable thiol reagent to label the periplasmic exposed cysteine and the other half is reacted with
blocking thiol reagent to protect the periplasmic-exposed cysteines in consequent labeling steps. To
specifically label cytoplasmic cysteines, the latter half of cells or ISOV is permeabilized to expose the
cytoplasmic cysteines to react with a detectable thiol reagent. The detectable thiol reagent is used to track
the labeled target protein from analyzed cells and ISOV. Note ISOV patterns of cysteine labeling (+) and
blocking (-) are mirror image of the whole cell patterns.
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1.7 PEGylation
PEGylation also employs maleimide reagents, but eliminates the need for protein
purification. In this method, the cysteine residues are modified by the covalent
attachment of poly(ethylene) glycol (PEG). PEG is a hydrophilic and linear, or branched,
polyether terminated with hydroxyl or functional groups. Monomethoxy PEG is the most
useful for modification when defining inner membrane protein topologies as it prevents
cross-linking from occurring.
PEG-Mal has a molecular mass of 5 kDa and is membrane-impermeable. Using
ethylenediaminetetracetic acid (EDTA) to permeabilize the outer membrane, PEG-Mal is
able to react with periplasmic residues of the protein in otherwise intact cells. EDTA
chelates the divalent metal ions of LPS to create a more permeable outer membrane but
still maintains the structure and organization of the bacterial cell envelope [93, 94]. Upon
crossing the EDTA-permeabilized outer membrane, PEG-Mal forms an irreversible
thiolate with any available periplasmic substituted cysteine. To asses if a substituted
cysteine is exposed to the cytoplasm, membrane preparations are performed before PEGMal labeling. Membrane preparations give a mix of membrane vesicles where
cytoplasmic substituted cysteines become exposed and are therefore available to react
with PEG-Mal. It is only TM substituted cysteines, buried in the hydrophobic space, that
are unable to form a thiolate with PEG-Mal. The PEG bulk creates an apparent band shift
of 10-25 kDa detectable by western blot, indicating that WecA has been modified [89,
93, 95] (Figure 12).
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Figure 12. Schematic representation of PEGylation and the theoretical Western blots based on
labeling pattern. In EDTA-permeabilized cells only periplasmic-exposed cysteines react with PEG-Mal
and show a band-shift. In membrane preparations cysteines on either side of the inner membrane react with
PEG-Mal and show a band-shift. TM residues orientated into the lipid bilayer are do not react with PEGMal and do not show a band-shift.
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1.8 Research objectives
1.8.1 Rationale
The topological model of the E. coli WecA was originally derived using the
TMHMM computer software and was experimentally refined by SCAM based on
biotinylation [20, 82]. From this information WecA was predicted to consist of 11
transmembrane domains (TMs), 5 periplasmic and 5 cytoplasmic loops, with the Nterminus located in the periplasm and the C-terminus in the cytoplasm (Refer to Figure
1). The cytoplasmic location of the C-terminus was independently confirmed by GFP
fusion [17, 18, 20].
However, WecA is difficult to over-express and purify, resulting in inconsistencies in
the biotin labeling experiments. Furthermore, functional residues detected by
mutagenesis are spread over several different cytoloops of the protein [5, 20], making the
need to determine the border of the TMs and cytoloops even more critical. Therefore, the
central goal of this research project was to determine the boundaries between specific
TMs and cytoloops with a reliable thiol labeling method such as PEGylation, which
bypasses the need for a purification step.

1.8.2 Specific Objectives
This thesis has two specific objectives:
1) To optimize the PEGylation assay in WecA. To address this objective, I first
demonstrated that PEGylation is specific and predictive of the topological location of the
targeted residue. The former was accomplished using increasing PEG-Mal concentrations
in labeling experiments performed on the cysteineless WecA (negative control) and
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WecA mutants with cysteine residues in periplasmic, membrane and cytoplasmic regions,
which were previously established by biotin-SCAM. The aim was to demonstrate that
PEG-Mal only labels available periplasmic cysteines in intact (EDTA-permeabilized)
cells but can also label cytoplasmic exposed cysteines in membrane preparations.
2) To refine the borders between cytoloops 1 and 4, and their corresponding
TMs, and to better characterize TMs IV and V. This objective involved creating
additional single substituted cysteine mutants in WecA in the areas of interest.
Translocation of each mutant derivative to the membrane was confirmed by Western blot
and complementation of OAg production in E. coli MV501 in vivo was verified. Finally,
the PEGylation assay was employed to refine the orientation of the substituted residues.

Chapter 2

Material and Methods

38
2.1 Bacterial strains, growth conditions, and reagents
The bacterial strains and plasmids used in this study are listed in Table 1. Bacteria
were grown at 37°C in Luria-Bertani (LB) medium supplemented with ampicillin (100
µg/mL) and/or tetracycline (20 µg/mL) and/or 0.2% (w/v) arabinose, as appropriate.
Chemicals were purchased from Sigma (St. Louis, MO, USA), unless otherwise stated.
Enzymes were purchased from Agilent Life Sciences and Chemical Analysis (Santa
Clara, CA, USA), New England Biolabs (Massachusetts, USA) and Roche Diagnostics
(Laval, QC, Canada). Oligonucleotide primers for sequencing and site-directed
mutagenesis (listed in Table 2) were purchased from Eurofins MWG Operon (Huntsville,
AL, USA). The QIAprep Spin Miniprep Kit by Qiagen (ON, Canada) and the HighSpeed Plasmid Mini Kit by Geneaid (New Taipei City, Taiwan) were used to isolate
plasmids.

2.2 Site-directed mutagenesis
2.2.1 Plasmid isolation
Plasmids were isolated by a small-scale plasmid DNA preparation. Briefly, 5 mL
overnight cultures (16 h at 37° using orbital shaking at 200 rpm) of E. coli DH5α
containing the appropriate plasmids were pelleted by centrifugation using a 1.5-mL
microcentrifuge tube at 16 000 x g for one min (repeated until the entire culture were
harvested). The supernatant was aspirated and the bacterial cell pellet was resuspended in
200 µL of PD1 Buffer (with RNase A). Two hundred µL of PD2 Buffer was added and
the tube was inverted to gently mix the suspension without shearing genomic DNA and
incubated at room temperature for at least 2 min, or until the lysate was homogeneous.
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Table 1. Bacterial strains and plasmids used in this study
Strain or Plasmid
E. coli Strains
DH5α

MV501
Plasmids
pBAD24
pJL7
pJL8
pJL15
pJL19
pJL20
pJL29
pSEF39
pSEF34
pSEF35
pSEF36
pSEF37
pSLL1
pSLL2
pSLL3
pSLL4
pSLL5
pSLL6
pSLL7
pSLL8
pSLL9
pSLL10
pSLL11
pSLL12
pSLL13
pSLL14
pSLL15
pSLL16
pSLL17
pSLL18
pSLL19
pSLL20
pSLL21
pSLL22
pSLL23

Relevant Properties

Reference or Source

E. coli K-12 F-Φ80lacZΔ M15
endA recA
hsdR(rK- mK-) supE thi gyrA relA
Δ(lacZYA-argF)U169
VW187; wecA::Tn10 TcR

Laboratory stock

Cloning vector
pKV1 expressing cysteineless
WecA
pJL7 expressing WecA-D35C
pJL7 expressing WecA-F143C
pJL7 expressing WecA-G181C
pJL7 expressing WecA-R209C
pJL7 expressing WecA-S362C
pJL7 expressing WecA-Y211C
pJL7 expressing WecA-V213C
pJL7 expressing WecA-M215C
pJL7 expressing WecA-D217C
pJL7 expressing WecA-S220C
pJL7 expressing WecA-L4C
pJL7 expressing WecA-S7C
pJL7 expressing WecA-S12C
pJL7 expressing WecA-L19C
pJL7 expressing WecA-A24C
pJL7 expressing WecA-K30C
pJL7 expressing WecA-K41C
pJL7 expressing WecA-L46C
pJL7 expressing WecA-S54C
pJL7 expressing WecA-F61C
pJL7 expressing WecA-V66C
pJL7 expressing WecA-Y69C
pJL7 expressing WecA-A73C
pJL7 expressing WecA-L77C
pJL7 expressing WecA-L83C
pJL7 expressing WecA-R25C
pJL7 expressing WecA-V27C
pJL7 expressing WecA-Q44C
pJL7 expressing WecA-G45C
pJL7 expressing WecA-Q104C
pJL7 expressing WecA-V107C
pJL7 expressing WecA-V110C
pJL7 expressing WecA-M112C

[96]
[20]

[57]

[20]
[20]
[20]
[20]
[20]
[51]
[51]
[51]
[51]
[51]
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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pSLL24
pSLL25
pSLL26
pSLL27
pSLL28
pSLL29
pSLL30
pSLL31
pSLL32
pSLL33
pSLL35
pSLL38

pJL7 expressing WecA-F114C
pJL7 expressing WecA-K116C
pJL7 expressing WecA-Y118C
pJL7 expressing WecA-S120C
pJL7 expressing WecA-L122C
pJL7 expressing WecA-Y124C
pJL7 expressing WecA-L133C
pJL7 expressing WecA-F136C
pJL7 expressing WecA-F139C
pJL7 expressing WecA-T141C
pJL7 expressing WecA-I149C
pJL7 expressing WecA-I47C

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Next, 300 µL of PD3 Buffer was added and mixed gently by inversion before
centrifuging at 16 000 x g for 10 min. The supernatant was added to a PD column, which
was placed in a 2-mL collection tube, and was centrifuged at 16 000 x g for 30 sec. The
flow-through was discarded and 400 µL of W1 Buffer was added to the PD column and
then centrifuged at 16 000 x g for 30 sec. Again, the flow-through was discarded and 600
µL of Wash Buffer (ethanol added) was added to the PD column and then centrifuged at
16 000 x g for 30 sec. The flow-through was discarded one more time before centrifuging
the PD column/collection tube at 16 000 x g for 3 min to dry the column matrix. The
dried PD column was transferred to a clean microcentrifuge tube and 50 µL of Elution
Buffer was added to the centre of the column matrix. After incubation at room
temperature for at least 2 min, or until the Elution Buffer was completely absorbed, the
tube was centrifuged at 16 000 x g for 5 min to elute the DNA.

2.2.2 Agarose gel electrophoresis
DNA fragments were separated by agarose gel electrophoresis on 0.8% agarose
gel (w/v) prepared in 1X TBE buffer (90 mM Tris-Borate, 1 mM EDTA [pH 7.5])
supplemented to a final concentration of 0.0005 mg/mL ethidium bromide. DNA samples
were loaded with 10X DNA agarose loading dye (50% glycerol [v/v], 0.1% bromophenol
blue [w/v], 100 mM EDTA [pH 7.5]), and the gels were subjected to electrophoresis at
100 V. A 1-kilobase pair (kb) or 100-base pair (bp) molecular weight GeneRule DNA
Ladder Marker (MBI Fermentas, Burlington, ON, Canada) was loaded in each gel as
DNA fragment size reference. DNA gels were visualized using a GelDoc 2000 Imaging
Unit and digitally processed with Multi-Analyst software (Bio-Rad, Hercules, CA, USA).
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2.2.3 Polymerase Chain Reaction (PCR) with Pfu Turbo DNA polymerase
WecA derivatives with single amino acid replacements were constructed with the
Quik-Change Site Directed Mutagenesis Kit by Stratagene (Agilent Life Sciences and
Chemical Analysis [Santa Clara, CA, USA]). The forward and reverse primer pairs
(Table 2) were designed to create the plasmids pSLL1 through pSLL38 encoding the
proteins listed in Table 1. The 38 individual mutations were made in the parental
WecAFLAG-7xHis gene (plasmid pJL7) expressing cysteineless WecA. See figure 13 for the
locations of the mutations indicated on the topological map of WecA. The PCR reactions
were prepared by mixing 1 µL of pJL7 template, 1 µL of dNTP mix (10 mM), 5 µL of
10X Pfu Turbo reaction buffer, 39.5 µL of double-distilled water (ddH2O), and 1.5 µL of
the forward and reverse primers of choice. Then, 0.5 µL of Pfu Turbo DNA polymerase
was added to each reaction volume (~50 µL) and PCR thermal cycling was performed
using a Bio-Rad Dyad Peltier Thermal Cycler. The PCR program involved an initial 30
sec denaturation at 95°C followed by 16 subsequent cycles of denaturation at 95°C for 30
sec, primer annealing at 55°C for 1 min, and extension at 68°C for 12 min. The PCR
reactions were digested overnight with 1 µL of the restriction enzyme DpnI at 37°C to
degrade any residual pJL7 plasmid DNA. Successful PCR amplification of pre- and postDpnI PCR products were verified by agarose gel electrophoresis as described above in
section 2.2.2. Next, 5 µL of confirmed products were introduced by transformation into
chemically competent DH5α E. coli as described below in section 2.4.1. Plasmids were
isolated from transformed colonies and the correct mutation confirmed by DNA
sequencing using the oligonucleotide primers 252 and 258 (Table 2). Colonies with the
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Table 2. Oligonucleotide primers used in this study
WecA strain
and mutants

Primer

Sequence*

WecAL4C

6325
6326

5’ – ACATATGAATTTATGTACAGTGAGTACT
5’ – AGTACTCACTGTACATAAATTCATATGT

WecAS7C

6327
6328

5’ – TTACTGACAGTGTGTACTGATCTCATC
5’ – GATGAGATCAGTACACACTGTCAGTAA

WecAS12C

6329
6330

5’ – ACTGATCTCATCTGTATTTTTTTATTC
5’ – GAATAAAAAAATACAGATGAGATCAGT

WecAL19C

6331
6332

5’ – TTATTCACGACATGTTTTCTGTTTTTT
5’ – AAAAAACAGAAAACATGTCGTGAATAA

WecAA24C

6333
6334

5’ – TTTCTGTTTTTTTGTCGTAAGGTGGCA
5’ – TGCCACCTTACGACAAAAAAACAGAAA

WecAR25C

6650
6651

5’ – TCTGTTTTTTGCCTGTAAGGTGGCAAAA
5’ – TTTTGCCACCTTACAGGCAAAAAACAGA

WecAK26C

6861
6862

5’ – TTTTTTGCCCGTTGTGTGGCAAAAAAA
5’ – TTTTTTTGCCACACAACGGGCAAAAAA

WecAV27C

6652
6653

5’ – TTTGCCCGTAAGTGTGCAAAAAAAGTC
5’ – GACTTTTTTTGCACACTTACGGGCAAA

WecAK30C

6335
6336

5’ – AAGGTGGCAAAATGTGTCGGTTTAGTG
5’ – CACTAAACCGACACATTTTGCCACCTT

WecAK41C

6337
6338

5’ – CCAAACTTCCGCTGTCGTCACCAGGGA
5’ – TCCCTGGTGACGACAGCGGAAGTTTGG

WecAQ44C

6654
6655

5’ – CGCAAACGTCACTGTGGATTGATACCT
5’ – AAGTATCAATCCACAGTGACGTTTGCG

WecAG45C

6656
6657

5’ – AAACGTCACCAGTGTTTGATACCTCTC
5’ – GAGAGGTGTCAAACACTGGTGACGTTT

WecAL46C

6359
6360

5’ – CGTCACCAGGGATGTATACCTCTCGTT
5’ – AACGAGAGGTATACATCCCTGGTGACG

WecAI47C

6863
6864

5’ – CACCAGGGCTTGTGTCCTCTCGTTGGG
5’ – CCCAACGAGAGGACACAATCCCTGGTG
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WecAS54C

6361
6362

5’ – GTTGGGGGGATTTGTGTTTACGCAGGG
5’ – CCCTGCGTAAACACAAATCCCCCCAAC

WecAF61C

6363
6364

5’ – GCAGGGATTGCCTGTACGTTCGGAATT
5’ – AATTCCGAACGTACAGGCAATCCCTGC

WecAV66C

6365
6366

5’ – ACGTTCGGAATTTGTGATTACTATATT
5’ – AATATAGTAATCACAAATTCCGAACGT

WecAY69C

6367
6368

5’ – ATTGTCGATTACTGTATTCCGCATGCA
5’ – TGCATGCGGAATACAGTAATCGACAAT

WecAA73C

6369
6370

5’ – TATATTCCGCATTGTTCTCTCTATCTC
5’ – GAGATAGAGAGAACAATGCGGAATATA

WecAL77C

6371
6372

5’ – GCATCTCTCTATTGTGCTGCTGCCGGT
5’ – ACCGGCAGCAGCACAATAGAGAGATGC

WecAL83C

6373
6374

5’ – GCTGCCGGTGTGTGTGTTTTCATTGGC
5’ – GCCAATGAAAACACACACACCGGCAGC

WecAQ104C

6658
6659

5’ – CGTGCCACCATATGTGCCGCTGTTGGC
5’ – GCCAACAGCGGCACATATGGTGGCACG

WecAV107C

6660
6661

5’ – ATACAGGCCGCTTGTGGCATTGTTATG
5’ – CATAACAATGCCACAAGCGGCCTGTAT

WecAV110C

6662
6663

5’ – GCTGTTGGCATTTGTATGATGGTGTTC
5’ – GAACACCATCATACAAATGCCAACAGC

WecAM112C

6699
7000

5’ – GGCATTGTTATGTGTGTGTTCGGCAAG
5’ – CTTGCCGAACACACACATAACAATGCC

WecAF114C

6664
6665

5’ – GTTATGATGGTGTGTGGCAAGCTTTAT
5’ – ATAAAGCTTGCCACACACCATCATAAC

WecAK116C

6701
6702

5’ – ATGGTGTTCGGCTGTCTTTATCTCAGT
5’ – ACTGAGATAAAGACAGCCGAACACCAT

WecAY118C

6666
6667

5’ – TTCGGCAAGCTTTGTCTCAGTAGCCTG
5’ – CAGGCTACTGAGACAAAGCTTGCCGAA

WecAS120C

6703
6704

5’ – AAGCTTTATCTCTGTAGCCTGGGTTAT
5’ – ATAACCCAGGCTACAGAGATAAAGCTT
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WecAL122C

6705
6706

5’ – TATCTCAGTAGCTGTGGTTATATCTTT
5’ – AAAGATATAACCACAGCTACTGAGATA

WecAY124C

6707
6708

5’ – AGTAGCCTGGGTTGTATCTTTGGCTCC
5’ – GGAGCCAAAGATACAACCCAGGCTACT

WecAG127C

6865
6866

5’ – GGTTATATCTTTTGTTCCTGGGAGATG
5’ – CATCTCCCAGGAACAAAAGATATAACC

WecAL133C

6709
6710

5’ – TGGGAGATGGTGTGTGGACCGTTTGGT
5’ – ACCAAACGGTCCACACACCATCTCCCA

WecAF136C

6668
6669

5’ – GTGCTCGGACCGTGTGGTTACTTCCTG
5’ – CAGGAAGTAACCACACGGTCCGAGCAC

WecAF139C

6670
6671

5’ – CCGTTTGGTTACTGTCTGACGCTATTT
5’ – AAATAGCGTCAGACAGTAACCAAACGG

WecAT141C

6711
6712

5’ – GGTTACTTCCTGTGTCTATTTGCCGTC
5’ – GACGGCAAATAGACACAGGAAGTAACC

WecAI149C

6674
6675

5’ – GTCTGGGCGGCCTGTAATGCGTTCAAC
5’ – GTTGAACGCATTACAGGCCGCCCAGAC
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Figure 13. Additional amino acid substitution locations in WecA (Modified from [51]). The WecA
topological model originally predicted with TMHMM and experimentally refined using SCAM was used as
a guideline for the selection of amino acids to mutate to cysteine. Black circles indicate critical residues
previously determined [22, 23, 69]. Black squares indicate the periplasmic (G181C) and cytoplasmic
(S362C) controls. Blue circles indicate mutations created in this study. Red circles indicate previous
mutations created that are tested in this study [20, 51, 92]. Bolded numbers indicate cytoplasmic loops.
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plasmids containing the desired amino acid replacements were stored in stock solution
(20% glycerol [v/v], 20% LB [w/v], ddH2O) at -80°C.

2.2.4 DNA sequencing
DNA sequencing was performed by the Core Molecular Biology Facility, York
University, ON, Canada and/or Eurofins MWG Operon, Huntsville, AL, USA.

2.3 Competent cell preparation
2.3.1 DH5α chemically competent cells
E. coli DH5α chemically competent cells were made by the rubidium chloride
(RbCl2) method adapted from Sambrook et al. [97]. From a frozen stock, a 5 mL
overnight culture of DH5α cells was grown. The overnight culture was added to 150 mL
of Super Optimal Broth (SOB) supplemented with 1.5 mL of 2 M Mg2+ and incubated
until an optical density (OD600) of 0.6 to 0.8 was reached. The culture was transferred to
sterile 25-mL plastic Nalgene tubes and chilled on ice for 15 min. Cells were harvested
by centrifugation at 5927 x g for 10 min at 4°C. The pellet was resuspended in 50 mL of
Buffer 1 (100 mM RbCl2, 50 mM MnCl2·4H2O, 30 mM potassium acetate [pH 7.5], 10
mM CaCl2·2H2O, and 15% glycerol [v/v] adjusted to a final pH of 5.8 with 0.2 M acetic
acid), placed on ice for 15 min, and centrifuged again. The pellet was resuspended in 12
mL of Buffer 2 (10 mM RbCl2, 75 mM CaCl2·2H2O, 10 mM MOPS, and 15% glycerol
[v/v] adjusted to a final pH of 6.8 with NaOH) and placed on ice for another 15 min.
Finally, cells were aliquoted into 200 µL fractions in 1.5 mL microcentrifuge tubes and
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were flash-frozen in an ethanol/dry ice bath. Chemically competent DH5α cell were
stored at -80°C until needed.

2.3.2 MV501 electrocompetent cells
Starting from a frozen stock, a 5 mL overnight culture of MV501 cells was grown
supplemented with tetracycline. The overnight was inoculated into 25 mL of LB with an
adjusted optical density (OD600) of 0.1 and grown for approximately 1 h, until the optical
density (OD600) reached 0.5 to 0.6. The culture was then chilled on ice for 10 min and
transferred to a sterile 25-mL plastic Nalgene tube. The cells were harvested by
centrifugation at 5927 x g for 10 min at 4°C. The supernatant was decanted and the pellet
was resuspended in 5 mL of cold, sterile ddH2O and centrifuged again at 5927 x g for 10
min at 4°C. Next, the supernatant was decanted and the pellet was resuspended in 1 mL
of cold, sterile ddH2O before being divided into two aliquots in 1.5-mL microcentrifuge
tubes, and topped up to 1 mL with cold, sterile ddH2O. The cells were harvested in the
tabletop centrifuge at 16 000 x g and resuspended in 1 mL of cold, sterile ddH2O. This
step was repeated once more before the final pellet was resuspended in 500 µL of 20%
glycerol/ddH2O. Electrocompetent MV501 cells were aliquoted into 50 µL volumes and
frozen at -80°C until needed.

2.4 Transformation of E. coli strains
2.4.1 Transformation of DH5α chemically competent cells
Chemically competent cells were thawed on ice and 5 µL of the PCR product was
added and mixed gently. The cells were left on ice for 30 min before heat-shock at 42°C
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for 2 min in a water bath. Then, 800 µL of SOC media was added to each aliquot and the
cells were incubated at 37°C for 2 h. One hundred twenty five µL of the recovered cell
suspension was spread on LB-Agar plates supplemented with ampicillin and left
overnight at 37°C.

2.4.2 Transformation of MV501 electrocompetent cells
Electrocompetent cells were thawed on ice and 2 µL of the appropriate plasmid
was added and mixed gently. The aliquots were transferred to chilled electroporation
cuvettes (Bio-Rad, CA, USA) and shocked at 1.25V using a Bio-Rad Gene Pulser to
obtain a time constant of at least 4. The cells were recovered in 800 µL of SOC medium
at 37°C for 2 h in a water bath. Then, 100 µL of the recovered cell suspension was spread
on LB-Agar plates supplemented with ampicillin and tetracycline and left overnight at
37°C.

2.5 Protein expression
2.5.1 Isolation of total membrane proteins
Five-mL cultures of MV501 transformed with a plasmid containing parental or
mutated wecA were incubated overnight at 37°C in LB supplemented with ampicillin and
tetracycline. The overnight cultures were inoculated into 25 mL flasks of LB with an
adjusted optical density (OD600) of 0.1 and grown for approximately 1.5 h, until midlogarithmic phase, where the optical density (OD600) reached 0.5 to 0.6. At this time
point, transcription of the plasmid-encoded wecA was induced by arabinose at a final
concentration of 0.2%, followed by incubation at 37°C for 3 h. Cells were harvested by
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centrifugation at 9 300 x g for 10 min at 4°C, washed with 0.9% NaCl, and pelleted again
at 9 300 x g for 10 min at 4°C. The cells were resuspended in 2 mL of 50 mM TAE
buffer (50 mM Tris-acetate [pH 8.5], 1 mM EDTA), supplemented with 80µL of
Complete-EDTA-free protease inhibitor, transferred to 15-mL Falcon tubes, and lysed
with the Constant Systems Ltd (UK) cell disruptor set to the “one shot” mode at 27 000
Psi. Cell debris was pelleted by centrifugation at 17 418 x g for 15 min at 4°C. Next, the
supernatant was transferred to microcentrifuge tubes and total membranes were pelleted
by ultracentrifugation at 30 966 x g for 35 min at 4°C. The membranes were resuspended
in 10 µL of TAE buffer and total protein concentration of the fractions was measured
immediately (see below).

2.5.2 Quantification of total membrane proteins
The concentration of protein in the total membrane fractions was measured using
the Bio-Rad Protein Assay, a modified Bradford Assay. One µL of membrane preparation
was diluted into 799 µL of ddH2O and 200 µL of Bio-Rad Protein Assay Dye for a final
volume of 1 mL. Similarly, standards containing 0, 2, 4, 6, 8, and 10 µg of bovine serum
albumin (BSA) were prepared. The absorbance of the standards and the membrane
preparations was measured at 595 nm. The values obtained from the standards were used
to construct a standard curve from which total protein concentration of each membrane
preparation was extrapolated.
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2.5.3 Detection of WecA and WecA mutant derivatives
Wild type WecA and the WecA mutants contained a C-terminal FLAG epitope so
that the proteins could be detected by Western blot analysis. A previously described
protocol was adapted to first resolve the proteins by gel electrophoresis [98]. Volumes of
membrane preparations containing 5-10 µg of total protein were combined with 3X
protein dye (0.875 M Tris [pH 6.8], 6% [w/v] SDS, 30% [v/v] glycerol, 0.03% [w/v]
bromophenol blue, 15% [v/v] β-mercaptoethanol) and separated by 14% Tris-glycine
SDS-PAGE (Running Gel: 14% ABA 44:0.8, 0.2% SDS, 0.375 M Tris-HCl [pH 8.0],
0.025% ammonium persulfate [APS], 0.025% N,N,N’,N’-tetramethylehtylenediamine
[TEMED]; Stacking Gel: 4.5% ABA 44:0.8, 0.1% SDS, 0.125 M Tris-HCl [pH 6.8],
0.025% APS, 0.025% TEMED) electrophoresis in 1X SDS buffer (25 mM Tris [pH 7.6],
200 mM glycine, 2.3 mM SDS) using the Mini-Protean 3 Cell (Bio-Rad, CA, USA) at
110-120V until the dye front ran through the stacking gel then increased to 130-150V. A
pre-stained Broad-Range Molecular Weight Marker (Bio-Rad) was included on all gels
as a molecular mass standard. Electrophoresis was performed until the dye front reached
the bottom of the protein gel.
Next, using the Bio-Rad Transblot system, proteins were transferred to
nitrocellulose membranes (Pall Life Sciences, Pensacola, FL). Briefly, the protein gel, a
nitrocellulose membrane, & blotting papers (VWR, UK), both cut to the size of the gel
were assembled as described elsewhere [97]. The transfer was performed in chilled
Transfer Tris-Glycine Buffer (25 mM Tris, 190 mM glycine, 0.1% SDS, 20% methanol)
at 250 mA for 1 h. After disassembling the transfer system, the nitrocellulose membranes
were washed with Tris Buffered Saline (TBS) (1 M Tris-HCl [pH 7.7] and 5 M NaCl).
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Then, the membranes were blocked overnight in Western Blocking Reagent (Roche)
diluted in TBS in a cold room. The following day, the membranes were rinsed with TBS
then incubated for at least 1.5 h in TBS with 1:10 000 Anti-FLAG M2 monoclonal
(mouse) antibody (Sigma, MO, USA) by rocking at room temperature. Next, the
membranes were washed with TBS three times for 10 min each by rocking at room
temperature. The membranes were incubated for at least 15 min in TBS with 1:20 000
Alexa Fluor 680 anti-mouse antibody and 700µL of Western Blocking Reagent by
rocking at room temperature. After 3 more washed with TBS, the membranes were
developed using the Odyssey V3.0 infrared imagining by Licor (Li-Cor, Lincoln, NB).

2.6 LPS production
2.6.1 LPS isolation
Previously described protocols were modified to isolate LPS from whole bacterial
cells [99, 100]. Parental MV501 or derivatives transformed with a plasmid parental or
mutated wecA were grown overnight as 5 mL cultures in LB supplemented with
ampicillin and tetracycline and 0.002% arabinose. The optical density (OD600) was
measured and the turbidity was adjusted to 2 in a final volume of 1.5 mL in 1X PBS.
From the normalized cell suspensions, whole cells were harvested by centrifugation at 16
000 x g in a tabletop centrifuge for 1 min at room temperature. The pellets were
resuspended in 150 µL of LPS Lysis Buffer (2% SDS, 4% β-mercaptoethanol, 10%
glycerol, 1 M Tris [pH 6.8], 0.01% bromophenol blue) and boiled for 10 min. Ten µL of
proteinase K (20 mg/mL) was added to the lysate, followed by vortexing and incubation
at 60°C in a water bath for 2 h. Then, 150 µL of pre-warmed 95% phenol was added and
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each sample was incubated at 70°C in a water bath for 15 min with vortexing every 5
min. Samples were then cooled on ice for 15 min before centrifugation at 16 000 x g for
10 min at room temperature to separate the aqueous phase containing the free LPS from
the phenol phase containing any residual cellular components. Next, the clear phase was
transferred to a clean microcentrifuge tube and 500 µL of ether was added to remove any
residual phenol by mixing it with the aqueous phase by gentle inversion. The samples
were centrifuged at 16 000 x g for 1 min at room temperature and the ether phase was
aspirated. LPS preparations were stored at -20°C.

2.6.2 Gel electrophoresis (Tricine SDS-PAGE)
Three µL of LPS was mixed with 3 µL of 3X protein dye and resolved by gel
electrophoresis in a 14% Tricine SDS-PAGE (Running Gel: 28.4% A-6-BA [49.5%
acrylamide-6% bisacrylamide], 33.2% gel buffer (3 M Tris [pH 8.5], 0.3% SDS), 10.4%
[v/v] glycerol, 0.2% APS, and 0.12% TEMED; Stacking Gel: 3.9% A-3BA [49.5%
acrylamide-3% bisacrylamide], 24.5% gel buffer, 1% APS, and 0.44% TEMED) using
the Mini-Protean 3 Cell (Bio-Rad). Gels were run at 50V through the stacking gel (~ 30
min) and 130V through the running gel until it ran off (~ 2 h), then run for 20 more min
in a two-buffer system (anode buffer (0.2 M Tris [pH 8.9]) and cathode buffer (0.1 M
Tris [pH 8.25], 0.1% SDS)).

2.6.3 LPS Silver Staining
After electrophoresis, gels were fixed overnight in a 60% methanol, 10% acetic
acid solution in order to visualize the LPS using a modified version of a previously
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described silver stain protocol [101]. Gels were rehydrated in a 7.5% acetic acid solution
with rocking for 30 min at room temperature. Next, the gels were oxidized in a 0.2%
solution of periodic acid with rocking for 30 min at room temperature. The gels were
washed three times with ddH2O for 10 min. A silver staining solution (0.18% sodium
hydroxide, 1.4% ammonium hydroxide and 19.4% silver nitrate) was applied for 15 min
followed by three more washed with ddH2O for 10 min. The gels were developed in a
0.05% citric acid, 10% methanol, 0.019% formaldehyde solution until the LPS banding
pattern appeared. The developing process was stopped quickly by three more washes
with ddH2O for 10 min. Images of LPS banding patterns were created by scanning the
gels using the HP Scanjet 4070 Photosmart Scanner.

2.7 PEGylation
2.7.1 Preparation of EDTA-permeabilized cells for labeling
Five-mL cultures of MV501 transformed with a plasmid containing parental or
mutated wecA were incubated overnight at 37°C in LB supplemented with ampicillin and
tetracycline. The overnight cultures were inoculated into 100 mL flasks of LB
supplemented again with ampicillin and tetracycline with an adjusted optical density
(OD600) of 0.1 and grown for approximately 1.5 h, until mid-logarithmic phase, where the
optical density (OD600) reached 0.5 to 0.6. At this time point, transcription (protein
expression) of the plasmid-encoded wecA was induced by arabinose at final concentration
of 0.2% and the cells were further incubated at 37°C for 3 h. Whole cells were harvested
by centrifugation at 9 300 x g for 10 min at 4°C, washed with 5 mL of HEPES/MgCl2
Buffer (50 mM HEPES [pH 6.8], 5 mM MgCl2), and pelleted again at 9 300 x g for 10
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min at 4°C. At this point, the pellets were resuspended in 1 mL of HEPES/MgCl2 and the
optical density (OD600) was measured, before being aliquoted in microcentrifuge tubes
into volumes with a normalized OD of 5. The cells were pelleted again in at 16 000 x g
for 1 min then resuspended in 100µL of HEPES/MgCl2 Buffer with 5 mM of 0.5 M
EDTA and 1 mM of 10 mM PEG-Mal. The reaction was allowed to proceed for one h at
room temperature before being quenched with 45 mM of 0.5 mM DTT for 10 min at
room temperature. The labeled cells were pelleted by centrifugation for 5 min, the
supernatant was removed, and the pellets were frozen at -20°C until use. Cell pellets were
thawed on ice before being resuspended in 1 mL of HEPES/MgCl2 Buffer supplemented
with 40 µL of Complete EDTA-free protease inhibitor (Roche). Cells were lysed and
total membrane preparations were collected following the protocol described above
(section 2.5.1) and resuspended in 10 µL of HEPES/MgCl2 Buffer.

2.7.2 Preparation of total membrane fractions for labeling
Five-mL cultures of MV501 transformed with a plasmid containing parental or
mutated wecA were incubated overnight at 37°C in LB supplemented with ampicillin and
tetracycline. The overnight cultures were inoculated into 100 mL flasks of LB
supplemented again with ampicillin and tetracycline with an adjusted optical density
(OD600) of 0.1 and grown for approximately 1.5 h, until mid-logarithmic phase, where the
optical density (OD600) reached 0.5 to 0.6. At this time point, transcription (protein
expression) of the plasmid-encoded wecA was induced by arabinose at final concentration
of 0.2% and the cells were further incubated at 37°C for 3 h. Whole cells were harvested
by centrifugation at 9 300 x g for 10 min at 4°C, washed with 5 mL of HEPES/MgCl2
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Buffer and pelleted again at 9 300 x g for 10 min at 4°C. At this point, the pellets were
resuspended in 1 mL of HEPES/MgCl2 and the optical density (OD600) was measured,
before being aliquoted in microcentrifuge tubes into volumes with a normalized OD of 5.
The cells were pelleted again in at 16 000 x g for 1 min then the supernatant was removed
and the pellets were frozen at -20°C until use. Cell pellets were thawed on ice before
being resuspended in 1 mL of HEPES/MgCl2 Buffer supplemented with 40 µL of
Complete EDTA-free protease inhibitor (Roche). Cells were lysed and total membrane
preparations were collected following the protocol described above (section 2.5.1). The
membranes were resuspended in 20 µL aliquots of HEPES/MgCl2 Buffer with 1 mM of
10 mM PEG-Mal and the reaction was allowed to proceed at room temperature for one h
before being quenched with 45 mM of 0.5 M DTT for 10 min. The labeled membranes
were pelleted by centrifugation for 5 min and resuspended in 10 µL of HEPES/MgCl2
Buffer.

2.7.3 Detection of PEGylated WecA
Parental WecA and the WecA mutants were detected by Western blot as
described above (section 2.5.3). PEGylated WecA resulted in a band shift of
approximately 10- to 25-kDa gain in apparent mass relative to parental WecA, producing
a characteristic double-band (see figure 11 again for reference).

2.8 Statistics
The data and figures are representative of typical experiments which were
repeated at least twice in each case.

Chapter 3

Results
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3.1 Rationale for this study
The current topological model of the E. coli WecA encompasses 11 TMs, five
periplasmic and five cytoplasmic loops, with the N-terminus located in the periplasm and
the C-terminus in the cytoplasm [17, 18, 20]. Several residues in cytoloops 2, 3 and 4 are
conserved among PNPT family members. Cytoloop 5, the least conserved, is thought to
recognize the carbohydrate moiety of the nucleotide sugar substrate (Figure 7). This
model was derived from a combination of in silico approaches and biotin-SCAM [20, 51,
92]. The classical biotin-SCAM method relies on protein purification to separate the
protein of interest from other native, unmodified proteins that contain exposed cysteines,
which can also be labeled. Because the WecA protein is difficult to purify we employed
SCAM combined with PEGylation. In this method, the cysteine residues are modified by
the covalent attachment of poly(ethylene) glycol and the labeled proteins can be readily
detected by Western blot by an increase in their apparent molecular mass. This approach
simplifies the analysis of cysteine-replaced mutant WecA proteins.
This research was aimed at optimizing the PEGylation protocol for WecA and
defining the borders between cytoloops 1 and 4, and their corresponding TMs, as these
cytoloops contain residues that are important for enzymatic activity. Moreover, TMs IV
and V also have residues predicted to interact with Und-P.
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3.2 Expression of WecA mutant enzymes in total membrane fractions
Amino acid substitutions, especially in the TMs, can lead to improper protein
folding and degradation. Therefore, SDS-PAGE and Western Blot were used to verify
that the mutant proteins constructed in this work are properly targeted to the membrane
and expressed at similar levels as the parental WecA. Typically, mutant proteins that
cannot properly insert in the membrane cannot be detected in membrane preparations or
they are barely detectable, suggesting protein degradation. Analysis of total membrane
fractions from bacteria expressing the 38 single-cysteine WecA mutants constructed here
were detectable by Western blot, revealing a polypeptide with an apparent mass of 36
kDa (Figure 14). These experiments also revealed a higher molecular weight band
corresponding to a WecA aggregate that is routinely seen under our experimental
conditions due to the mild denaturation required for visualization of membrane proteins
[69]. The single-cysteine mutant proteins were expressed at comparable levels to that of
parental WecA, although some variation between mutants can be attributed to loading
differences.
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Figure 14. Expression of WecA mutant derivatives. Total membrane fractions were prepared from E.
coli MV501 transformed with plasmids encoding wecA mutants. Bacteria were grown until midexponential phase and protein expression was induced by arabinose. Cells were harvested, lysed, and the
membrane protein fractions were isolated by ultracentrifugation, and a sample of each mutant (5-10µg of
protein) was separated by 14% SDS-PAGE. Proteins were transferred to a nitrocellulose membrane, and
WecA was detected by anti-FLAG, with Alexa Fluor 680 anti-mouse used as secondary antibody. The
positions of the molecular mass markers are indicated on the left, the mutations on top (L=ladder), and the
protein monomers and aggregates on the right.
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3.3 Complementation of O-antigen production by WecA mutant enzymes
A protein that is topologically correct should also be functional unless the Cys
either replaces a catalytic residue or causes a localized structural perturbation affecting
enzyme function. Therefore, we examined the effects of the single-cysteine mutations on
OAg production by in vivo complementation of E. coli strain MV501 containing a
wecA::Tn10 insertion. MV501 competent cells were transformed with plasmids encoding
wecA or one of the wecA substituted cysteine mutants. LPS was isolated from the
transformants and visualized by silver staining as described in Materials and Methods
(Figure 15). The amount of OAg produced by each mutant was compared to parental
WecA. K41C, A73C, Q104C, L122C, F136C, and F139C WecA proteins mediated much
less polymeric OAg, while M112C, K116C, and T141C fail to complement. These
differences, compared to parental WecA (pJL7), would suggest diminished in vivo
function. However, the differences could also be due to loading differences, as the mutant
proteins are stably inserted in the membrane. Similar observations were made with the
previously constructed mutants D35C and F143C [20, 92].
Furthermore, similar results were also observed with the replacement of various
aromatic residues with conservative, polar mutations located in TMs IV and V, the
putative polyisoprenol recognition sequence (PIRS motif). The PIRS motif is predicted to
be in transmembrane spanning regions and involved in specific interactions between the
hydrophobic residues of the motif and the isoprenoid [5, 102]. If Und-P interacts with
WecA at this site by multiple hydrophobic interactions, then increasing the polarity of the
contact region should result in a proportional decrease in polymeric OAg production.
While the mutants constructed by E. Haggerty, a previous M.Sc. student in our
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Figure 15. Complementation of OAg production by wild-type WecA and mutant derivatives. LPS was
isolated from E. coli MV501 transformed with a plasmid encoding either wecA or a wecA mutant. LPS
structural components were resolved by electrophoresis on a 14% Tricine SDS-PAGE, which was fixed
overnight and silver stained. The plasmids pJL7 and pBAD24 represent the positive and negative controls,
respectively.
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laboratory, were not cysteine-substitutions, the polar conservative mutations, such as
phenylalanine and tryptophan to tyrosine and phenylalanine, did affect polymeric OAg
production, especially in multiple-residue mutant constructs, indicating that they play a
role in WecA function [5]. Similarly, cysteine is a polar, non-conservative mutation that
could also increase the polarity of the region. Therefore, various cysteine substitutions in
TMs IV and V appear to also diminish polymeric OAg production supporting the idea
that multiple residues in this area play a role in WecA function.

3.4 PEGylation of WecA mutants
3.4.1 Optimization
PEGylation is a relatively recent approach for bacterial inner membrane proteins
[89, 93, 95, 103, 104]. Therefore, it was necessary to optimize PEGylation of WecA
before proceeding to the full characterization of the panel of mutants. First, we assessed
the specificity of the label to make sure it could only detect exposed cysteine residues in
the protein. The method employed is simplified to include labeling of EDTApermeabilized cells and membrane preparations. The previously used and experimentally
determined periplasmic control, G181C, was compared to the negative, cysteineless
WecA encoded by pJL7 [20, 51]. Each control was labeled with increasing
concentrations of PEG-Mal to demonstrate that PEGylation is functional and to
determine the necessary amount of PEG-Mal that was required to obtain a band-shift.
While 0.5 mM PEG-Mal was sufficient to visualize a detectable band-shift by Western
blot, we chose to use 1 mM PEG-Mal in the labeling reactions to ensure there was

64
enough reagent available to PEGylate available cysteines in EDTA-permeabilized cells
(Figure 16).
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Figure 16. PEG-Mal labeling of cysteine-substituted WecA of E. coli in crude membrane
preparations. The various cysteine-substituted mutants were disrupted by a cell disruptor set at 27 kPsi.
The crude membrane fractions were isolated by ultracentrifugation and divided into four 20 µL aliquots.
One aliquot was incubated with HEPES/NaCl buffer alone, whereas the remaining three aliquots were
incubated with increasing concentrations of PEG-Mal (5 kDa). The reaction was quenched by addition of
45mM DTT, and a sample of each aliquot (5-10 µg of protein) was separated by 14% SDS-PAGE. Proteins
were transferred to nitrocellulose membrane, and WecA was detected by anti-FLAG, with Alexa Fluor 680
anti-Mouse used as secondary antibody. The positions of the molecular mass markers are indicated on the
left. G181C = periplasmic cysteine (should label with PEG-Mal); pJL7 = cysteine-less (should not label
with PEG-Mal).
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Second, we used additional replacements of known topology to evaluate if the
PEGylation occurs as expected. The periplasmic control (G181C) should be labeled with
the membrane-impermeable PEG-Mal in an EDTA-permeabilized cell, and in membrane
preparations, and the PEG bulk will create an apparent band shift on a Western blot. The
cytoplasmic control S362C should not be labeled with the membrane-impermeable PEGMal in EDTA-permeabilized cells, and not cause a band shift on a Western blot.
Contrarily, S362C should be labeled with PEG-Mal in membrane preparations and cause
a band shift as membrane preparations create mixed inverted vesicles allowing
cytoplasmic exposed and bordering TM residues to react with PEG-Mal [20, 22, 23, 51,
92]. Finally, based on the topological prediction and experimental results employing
SCAM, we chose F143C as the TM control [20]. F143C is predicted to be buried in a
hydrophobic space and it was not accessible to biotinylation [20]; therefore, it should not
react with PEG-Mal.
Both periplasmic (G181C) and cytoplasmic (S362C) controls reacted with PEGMal as expected. G181C showed an additional PEGylated double-band on Western blots
in EDTA-permeabilized cells and in membrane preparations. S362C was not labeled in
EDTA-permeabilized cells but showed a band-shift in membrane preparations. F143C
was not labeled in EDTA-permeabilized cells, as expected. However, this residue
consistently and repeatedly showed a double-band in membrane preparations (Figure 17).
This suggests that F143C is partially exposed to the cytosol, or is at least facing outwards
from the lipid bilayer, so that PEG-Mal can react with the substituted cysteine in the
presence of water.
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Despite that the expected "TM control" denoted a residue that was accessible
from the cytosol (see below), the results with the periplasmic- and cytoplasmic-exposed
residues confirmed their previously predicted location. Therefore, the optimization
experiments suggested that PEGylation is an attractive alternative to biotin-SCAM, as it
eliminates the need for purification.
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Figure 17. PEG-Mal labeling of cysteine-substituted WecA in E. coli controls in EDTA-permeabilized
cells. The various cysteine-substituted mutants were grown until mid-exponential phase until protein
expression was induced by arabinose. Cells were harvested and resuspended in 1mL of HEPES/MgCl2
buffer and divided into aliquots of an OD of 5. One aliquot was incubated with incubated with 1mM PEGMal (5 kDa) and 5mM EDTA. The reaction was quenched by addition of 45mM DTT, then the membrane
protein fractions were isolated by ultracentrifugation, and a sample of each aliquot (5-10µg of protein) was
separated by 14% SDS-PAGE. The other aliquot was treated with 1mM PEG-Mal (5 kDa) after the
membrane protein fractions were isolated, and then the reaction was quenched with 45mM DTT before a
sample of each aliquot (5-10µg of protein) was separated by 14% SDS-PAGE. Proteins were transferred to
nitrocellulose membrane, and WecA was detected by anti-FLAG, with Alexa Fluor 680 anti-Mouse used as
secondary antibody. The positions of the molecular mass markers are indicated on the left, the condition on
the top, aggregates, monomers and PEGylated WecA on the right, and PEGylated WecA mutant derivatives
at the bottom. pJL7 = cysteine-less WecA (negative control); G181C = periplasmic cysteine; F143C = TM
cysteine; S362C = cytoplasmic cysteine.
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3.4.2 Cytoloop 1
In a previous study [19], the topological location of aspartic acid 35 differed
experimentally from the in silico prediction. Biotin-SCAM suggested that this residue is
located in the periplasm, in contrast to the location in cytoloop 1 predicted in silico. Also,
replacement of aspartic acid 35 with cysteine or glycine resulted in reduced OAg
production in E. coli MV501 and also reduced enzymatic activity in vitro, suggesting this
residue plays a role in WecA function [20, 23]. Therefore, it was important to determine
the location of Asp-35 as well defining the boundaries of cytoloop 1. For this purpose,
several replacements were made in residues of the predicted cytoloop 1, which included:
A24C, R25C, V27C, K30C, D35C, K41C, Q44C, G45C, and L46C (Figure 18). More
specifically, A24C and R25C do not show labeling in intact cells or membrane
preparations, suggesting they are within TM I. V27C does not show any labeling in intact
cells but does in membrane preparations suggesting a cytoplasmic orientation.
Poor expression of Q44C and G45C may indicate that these residues are located
at the border of TM II, which can cause the protein to be unstable and can make the
PEGylation results inconclusive. Mutating these residues to alanine should restore the
stability of the protein, indicating that they are important to WecA stability and are
located at the TM border. K30C, D35C, K41C, and L46C all label in membrane
preparations, but not intact cells, again suggesting a cytoplasmic orientation. Therefore,
K30C, D35C and K41C are located in the cytoplasm, matching the predicted location.
Q44C, G45C, and L46C are most likely found at the border of TM II, as predicted,
although labeling of L46C suggests that it is exposed to the cytoplasm. This could be due

70

Figure 18. PEG-Mal labeling of cytoloop 1 of E. coli cysteine-substituted WecA in EDTApermeabilized cells and crude membrane preparations. Samples were prepared and blotted as described
above in figure 17. The positions of the molecular mass markers are indicated on the left, aggregates,
monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. pJL7 =
cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control
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to L46C being partially exposed to the cytosol, as it is located at the border of the TM
and is therefore available to react with PEG-Mal [89]. These results demonstrate the
specificity and sensitivity of the PEGylation method, and support the predicted
cytoplasmic orientation of the D35 residue.

3.4.3 TMs I, II and III
Additional single-cysteine mutations were created throughout TMs I, II and III in
the WecA protein, as these regions have not been thoroughly investigated. The mutations
include: L4C, S7C, S12C, L19C, S54C, F61C, V66C, Y69C, A73C, L77C, and L83C.
Based on the PEGylation results in EDTA-permeabilized cells and membrane
preparations, all the residues are located in their predicted locations, except L4C which
could potentially be included within the boundary of TM I based on the lack of band-shift
pattern in EDTA-permeabilized cells (Figure 19). Interestingly, L4C and S7C show a
faint band-shift in membrane preparations indicating some exposure to PEG-Mal. This is
most likely due to their proximity to the N-terminus of WecA as membrane preparations
create mixed inverted vesicles such that any residues close to the edge of the TM border
can be partially exposed and therefore available to interact with PEG-Mal. This is also
seen with V66C and A73C in membrane preparations while Y69C is labeled in EDTApermeabilized cells supporting its predicted periplasmic orientation. Therefore, with the
exception of residues located at the TM borders that may account for the band-shift
patterns seen in membrane preparations, PEGylation supports the predicted locations of
all the residues in TMs I, II and III. In addition, the results provide experimental
refinement supporting the topological assignment of this region.
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Figure 19. PEG-Mal labeling of TMs I, II, and III of E. coli cysteine-substituted WecA in EDTApermeabilized cells and crude membrane preparations. Samples were prepared and blotted as described
above in figure 17. The positions of the molecular mass markers are indicated on the left, aggregates,
monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. pJL7 =
cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control
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3.4.4 TMs IV and V
Currently, there is little known about the physical interaction between isoprenoids
and their enzymes. The direct interaction between Und-P and WecA had not been
demonstrated even though molecular modeling techniques have revealed specific
interactions between hydrophobic residues in the PIRS peptides and the isoprenoids of
other proteins. Residues located in TMs IV and V are of interest as they are in an
arrangement that resembles a putative PIRS motif [102, 105, 106]. Both TMs are rich in
aromatic residues, and we have previously speculated they may be partially exposed to
the cytoplasm creating an interaction site (“pocket”) with the α-isoprene unit of Und-P
[5]. Previous experimental attempts show complementation defects and transferase assays
as support for the hypothesis that Und-P interacts with WecA, however kinetic analyses
remain inconclusive [5]. This is largely due to the fact that WecA cannot be purified to
homogeneity in a large enough quantity to perform these functional analyses. Therefore,
another objective of this study was to utilize the PEGylation protocol to support the
hypothesis that Und-P interacts specifically with WecA via multiple hydrophobic
interactions, as purification is not required. In fact, PEGylation of this region facilitates
additional desired structural information of WecA. So, most of the residues mutated
along TMs IV and V were originally predicted to be part of the putative PIRS motif [5] in
addition to other surrounding residues in this region.
V107, V110, M112 and F114 label in membrane preparations but not in EDTApermeabilized cells suggesting exposure to the cytosol. Q104 is PEGylated in membrane
preparations, confirming it is on the edge of the cytoplasmic border of TM IV (Figure
20).
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Figure 20. PEG-Mal labeling of TMs 4 and 5 (PIRS motif) of E. coli cysteine-substituted WecA in
EDTA-permeabilized cells and crude membrane preparations. Samples were prepared and blotted as
described above in figure 17. The positions of the molecular mass markers are indicated on the left,
aggregates, monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot.
pJL7 = cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control.
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K116 does not label in either condition, confirming its predicted location in TM IV and
most likely facing into the lipid bilayer. Next, Y118 does not label in EDTApermeabilized cells but does show a band-shift in membrane preparations suggesting it is
exposed and part of the PIRS motif. Next, S120, L122 and Y124 show a band-shift in
both conditions suggesting that these residues are outside on TM IV and exposed to the
periplasm (Figure 19). It is quite possible with the way WecA could be folded and tilted
in the membrane that this part of TM IV is exposed.
The TM V residues L133, F136, F139 and I149 do not label in EDTApermeabilized cells but do label in membrane preparations suggesting exposure from the
cytoplasm. T141 does not show a band-shift in either condition confirming its predicted
TM location and is therefore facing into the bilayer. F143 shows a band-shift in
membrane preparations, and is therefore also exposed to the cytoplasm (as discussed
above in section 3.4.1). This can be further supported by the fact that F143C does not
complement OAg production [20, 92] and is therefore a critical residue for WecA
function.

3.4.5 Cytoloop 4 (VFMGD motif)
Arginine 209 [20, 92] and the highly conserved VFMGD motif [51] include
additional controversial regions that differed experimentally from the predicted topology.
R209 was predicted to be in the cytosol while SCAM placed it in the periplasm.
Contrarily, the VFMGD motif was predicted to be in TM VIII although it was thought to
have a catalytic nucleophile based on modeling against the VFMGD motif in MraY [51,
72]. It is now partially reassigned to the cytosol as biotinylation of aspartic acid 217
provided indications of a cytosolic location. However, the other residues were
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inaccessible to biotinylation, making their topological assignment difficult. Additional
experiments indicate that the highly conserved VFMGD motif is likely a region in PNPT
proteins that is involved in the binding and/or recognitions of the nucleotide moiety of the
nucleoside phosphate precursor by contributing to the active site [51].
Using this information, residues R209C, Y211C, V213C, M215C, D217C, and
S220C were assessed with the PEGylation protocol. None of these substituted cysteine
residues label in EDTA-permeabilized cells, but they label in membrane preparations,
suggesting the entire region is located in the cytoplasm (Figure 21). Based on the labeling
pattern, S220C may be right at the edge of TM VIII as its band-shift is less intense
compared to the other cytoplasmic residues but is still partially exposed to cytosol,
allowing it to react with PEG-Mal [89]. The PEGylation results support the proposed
cytoplasmic orientation of the VFMGD motif. This location is consistent with the
proposed role of the region in the binding and/or recognition of nucleotide moiety as it
would need to be exposed to the cytosol to interact with the nucleoside phosphate
precursor. Additionally, if all the residues of this highly conserved region are located in
the cytoplasm then the positively charged R209, two residues away, cannot be in the
periplasm. Therefore, PEGylation of R209C supports the predicted cytosolic location.
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Figure 21. PEG-Mal labeling of cytoloop 4 of E. coli cysteine-substituted WecA in EDTApermeabilized cells and crude membrane preparations. Samples were prepared and blotted as described
above in figure 17. The positions of the molecular mass markers are indicated on the left, aggregates,
monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. pJL7 =
cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control

Chapter 4

Discussion
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Discussion
Elucidating the topology of WecA and uncovering critical functional residues in
this protein provides a template to better understand the mechanism of action of PNPT
family members. This study involved working with WecA in its native environment at
the inner membrane. Currently, the structural characterization of PNPTs has been
hampered by difficulties encountered with their overexpression and purification [18, 92].
Many previous topological methods miss important biological interactions (in silico),
disrupt secondary structure of the protein (reporter fusions), and require purification
(SCAM with biotinylation). PEGylation provides the advantage that it does not require
protein purification, as it allows direct detection of labeled cysteine residues by a 10-25
kDa shift in the apparent mass of the protein in its native membrane location.
Aspartic acid 35 and arginine 209 are examples of WecA residues that differed
experimentally from the predicted topology. The biotin-SCAM suggested that both
residues were located in the periplasm, while the topology software predicted a cytosolic
location [20, 92]. Replacement of aspartic acid 35 with cysteine resulted in loss of
complementation (O7 LPS synthesis in E. coli MV501) [20, 92]. PEGylation results of
this work support a cytoplasmic location of both D35 and R209 as these residues only
labeled with PEG-Mal in membrane preparations, and not EDTA-permeabilized cells.
We interpreted the differences between biotinylation-SCAM and PEGylation-SCAM as
due to protein denaturation during purification.
Additional mutations were created along predicted cytoloop 1, including the
borders of TMs I and II, to experimentally define the boundaries of the loop and the
borders of the adjacent TMs. The borders of TM I can be updated to include L4, A24 and
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R25 within the TM while V27 is located in the cytoplasm. This demonstrates the
sensitivity and specificity of PEGylation as only one residue K26 separated the
cytoplasmic border of TM I. At the other end of cytoloop 1 Q44, G45, and L46 are all
labeled in membrane preparations, and not EDTA-permeabilized cells, indicating a
cytoplasmic orientation and again refining the border to TM II.
Next, the highly conserved VFMGD motif was experimentally assessed with
PEGylation as it is now partially located in the cytosol as previous biotinylation of
aspartic acid 217 greatly changed the putative TM boundaries. The other residues were
inaccessible to biotinylation, and may be in the TM, while the border on the other side of
the VFMGD motif remains unrefined [51]. Again, using PEGylation, the entire region of
substituted cysteines can be placed within cytoloop 4. Even S220 is labeled, albeit not as
strongly, indicating that the cytoplasmic border of TM VIII can be updated. Moreover, all
the substituted cysteines in the VFMGD motif and surrounding area tested with
PEGylation provided conclusive results, unlike previous experimental attempts using
biotinylation.
Initially, F143C was chosen as a control residue in a TM location because
previous experimental evidence using SCAM with biotinylation suggested it was
inaccessible. When labeling F143C with PEG-Mal in EDTA-permeabilized cells, there
was no observable band-shift, as expected for a transmembrane location. However,
F143C was consistently and reproducibly labeled in PEGylated membrane preparations.
Previous research in our laboratory has suggested that F143 might be part of a region
corresponding to a potential Und-P binding site [5], which spans TMs IV and V. These
two TMs contains an unusual density of bulky aromatic residues, such as phenylalanine
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and tryptophan, which may be important in interacting with the Und-P lipid substrate by
creating a "pocket" accessible from the cytoplasm. Our results also suggest that these
residues in both TMs would face each other rather than establishing interactions with
membrane glycerophospholipids, which will make the residues inaccessible to PEG-Mal
labeling.
After the experimental work in this study was completed, we submitted the WecA
amino acid sequence to the iterative threading assembly refinement (I-TASSER) server
for ab initio three-dimensional (3D) modeling. I-TASSER is an integrated web-based
platform for fully automated protein structure and function prediction. It generates a 3D
atomic model from multiple threading alignments and iterative structural assembly
simulations using an amino acid sequence without the common biochemical limits set by
human intervention. Structurally matching the 3D model with other known proteins
allows the function of the protein of interest to be inferred. Full-length secondary and
tertiary structure predictions and functional annotations on ligand-binding sites are some
of the usual outputs from a typical server. Moreover, I-TASSER is consistently ranked as
the best method for computational structural biology [107, 108].
Comparing the PEGylation results with the 3D model demonstrated a remarkable
agreement between experimental data and the ab initio structural prediction. The
experimentally assigned location of nearly every residue that was mutated to cysteine and
PEGylated agreed with the structural model. Moreover, the structural model supported
the hypothesis that many of the residues located in TMs IV and V, especially the
phenylalanines form a "cavity" opened to the cytoplasmic space, which could
accommodate the lipid carrier. Additionally, the three residues S120, L122, and Y124 at

82
the border of TM IV that show a band-shift in EDTA-permeabilized cells are supported
by the model to be exposed to the periplasm in loop 2 (see Appendix A). This recent
automated 3D model is well supported by the current experimental data, suggesting that
PEGylation is sensitive, specific and accurate method to elucidate the topology of a
membrane protein like WecA.
In summary, the PEGylation approach employed here has allowed us to
characterize and refine the topology of WecA. Currently, four other integral membrane
proteins are being topologically mapped in our laboratory using the PEGylation protocol
including E. coli WaaL, Pseudomonas aeruginosa WaaL, E. coli WcaJ, and Burkholderia
cenocepacia ArnT.
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Appendix A

Ab initio 3D model of WecA. The 3D model was derived using the I-TASSER server. A) View from the
side. B) View through the bilayer. C) View from the periplasm. D) Tilted view from the side. The residues
located along TMs IV and V that label in membrane preparations (suggesting exposure to the cytosol) are
highlighted in orange. The residues located along TMs IV and V that do not label in membrane
preparations (suggesting they are facing into the bilayer) are highlighted in blue. The residues S120, L122,
and Y124 located along TMs IV and V that label in EDTA-permeabilized cells (suggesting exposure to the
periplasm) are highlighted in red. Other critical aspartic acids D35, D90, D91, D156, and D159 are
highlighted in yellow while H278 is highlighted in magenta and A286 is highlighted in pale blue.
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